Diebold Nixdorf, Incorporated

Fundamentals4.0
Price Action3.0
News Sentiment5.0
AI Rating
4.0

Key Drivers

  • Cash Flow Reversal
  • Elevated Leverage
  • Thin Margins

AI
AI Summary

4.0

DBD is an execution-sensitive, leveraged turnaround—not a conventional growth story—where margin-led earnings upside is credible only if recurring services growth and working-capital discipline restore sustainable free-cash-flow generation and enable debt reduction; investors should await clear cash-conversion improvement before treating the stock's pullback as an opportunity.

MarginExpansion
CashFlowRisk
Deleveraging‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

4.0

Key Financial Insights:

  • •Cash Flow Reversal
  • •Elevated Leverage
  • •Thin Margins

DBD's strong 2025 cash generation is overshadowed by recent cash burn, declining liquidity, high leverage, and thin margins, warranting caution at its elevated valuation.

HighLeverage
CashFlowRisk

Price Behavior

3.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Persistent downtrend
  • •Critical support
  • •Rebound unconfirmed

DBD remains bearish over the last month, with $63.20–$63.50 support critical; a break lower signals further downside, while reclaiming $65.00 is needed to improve momentum.

Bearish
SupportWatch
Support Level: $63.20–$63.50
Resistance Level: $64.90–$65.30

Orderly but persistent decline of about 9.6% over the last month

Sentiment & News

5.0

Key News Insights:

  • •Positive analyst sentiment
  • •Rising institutional ownership
  • •Mixed share performance

Diebold Nixdorf shows constructive analyst and institutional support, but investors should expect near-term volatility.

AnalystOptimism
PriceVolatility

The news is cautiously positive for DBD's outlook, though short-term price swings may persist